Scientific analysis that evolves with your legal strategy
Fyled provides the structured scientific foundation underneath complex biotech matters — helping attorneys iterate faster, maintain scientific continuity, and identify non-obvious technical and strategic risks as legal strategy evolves.
Scientific analysis services
Structured scientific analysis supporting attorney-led biotech IP strategy.
FTO Analysis
Claim-relevant technical analysis across patents, products, sequences, constructs, mechanisms, and implementation pathways.
Patent Landscape
Structured landscapes showing owners, priority positions, technical overlap, differentiation, and claim-relevant positioning.
Diligence
Scientific review of portfolios, technical overlap, implementation risk, and claim-relevant positioning for diligence workflows.
Sequence & Mechanism
Focused scientific analysis for biologics, gene therapy, antibodies, RNA therapeutics, CRISPR systems, delivery platforms, and engineered constructs.
A SCIENTIFIC FOUNDATION FOR BIOTECH IP STRATEGY
Science evolves. Legal strategy evolves. The scientific foundation should not need to be rebuilt every time.
Biotech matters often require attorneys to connect patents, publications, sequences, mechanisms, products, and scientific expertise into a coherent technical picture.
FYLED creates a persistent scientific foundation that evolves alongside the legal strategy, helping attorneys move faster, maintain continuity, and identify non-obvious technical and strategic risks.
WHY FYLED
Patent overlap and competitive overlap are not the same thing.
Traditional analysis evaluates legal proximity. FYLED evaluates scientific proximity — helping attorneys identify risks, opportunities, and strategic relationships that may not be obvious from patents, claims, citations, or landscapes alone.
🔍 Click image to enlarge
The real risk is often hidden in the science behind the documents.
TECHNOLOGY-SPECIFIC IP COMPLEXITY
Different biotech modalities hide risk in different places.
FYLED supports scientific interpretation across therapeutic modalities where patent risk depends on mechanism, sequence, construct, delivery, chemistry, biology, or competitive convergence.
Chemistry and modality systems
Biology and genetic medicine
Emerging and convergent areas
Why biotech attorneys use FYLED
FYLED provides a persistent scientific foundation that evolves alongside the legal strategy.
Move faster
Initial technical foundation in days, not weeks.
Reduce coordination overhead
Less fragmented scientific input across the matter.
Handle complex biotech
Support across biologics, RNA, CRISPR, delivery systems, and small molecules.
Go deeper where needed
Claim, sequence, construct, mechanism, and delivery-system level analysis.
Maintain consistency
The scientific foundation carries forward as the legal question shifts.
Refine strategy with confidence
Stay focused on legal strategy while FYLED handles the evolving science.
REPRESENTATIVE FEEDBACK
Used across boutique and Am Law 50 biotech IP matters
FYLED supports attorney-led work across different firm sizes, from boutique IP counsel needing deeper biotech coverage to matters reviewed through large-firm legal workflows.
“
The ability to iterate quickly without rebuilding the scientific context every time was extremely valuable as the legal strategy evolved.
Boutique biotech IP counsel
“
The structured scientific foundation allowed the legal analysis to evolve without repeatedly reconstructing the technical context.
Am Law 50-reviewed biotech matter
“
FYLED surfaced technically relevant competitive movement that was not obvious from conventional patent review alone.
Technical diligence engagement
Alex Harwig, PhD
Founder & Scientific Lead
25+ years in biotech R&D, translational science, and claim-aware technical analysis.
View LinkedIn
FOUNDER AND SCIENTIFIC LEAD
Scientific depth for complex biotech matters
Fyled was founded to bring deep scientific interpretation into attorney-led IP workflows. The work draws on experience across oncology, RNA biology, gene therapy, virology, protein engineering, assay development, and therapeutic platform evaluation — with a focus on translating complex science into claim-aware technical analysis.
- 25+ years of biotech R&D experience
- Experience supporting approximately 40 biotech patent families
- Scientific analysis across biologics, RNA therapeutics, CRISPR systems, antibodies, delivery platforms, and engineered constructs
- Technical translation between scientists, executives, and IP counsel
FAQ
What exactly does Fyled deliver?
Fyled delivers structured biotech technical analysis for IP attorneys. Typical outputs include patent landscape maps, claim-to-technology comparison tables, sequence and construct comparisons, mechanism-based differentiation analysis, technical overlap mapping, and attorney-directed follow-up analysis.
Is this legal advice or a freedom-to-operate opinion?
No. Fyled provides scientific and technical analysis only. Legal advice, freedom-to-operate opinions, infringement opinions, validity opinions, enforceability opinions, and claim construction must come from counsel.
What types of scientific matters do you support?
Fyled focuses primarily on biotech and life-science matters where the innovation has multiple technical layers: patents, claims, products, sequences, constructs, mechanisms, delivery systems, assays, implementation pathways, and competitive positioning. We can also support other deep-science matters, including pharma, medical devices, diagnostics, advanced materials, semiconductors, and other technically complex fields where careful scientific interpretation is needed.
How quickly can you turn analysis around?
Typical initial technical foundations take 5–10 business days depending on scope. Focused follow-up analysis is usually handled within 24–48 hours.
How do you handle confidentiality?
Fyled treats client materials as confidential and works through attorney-directed workflows where appropriate. Client materials are handled in secure workspaces and are not used to train public AI systems. We do not place confidential client information into consumer ChatGPT or public AI tools. Engagement-specific confidentiality terms can be handled through NDA or counsel-directed agreement.
MOVE FROM DOCUMENTS TO DECISIONS
Working through a complex biotech IP matter?
Start with a scientific foundation that helps counsel and life-science teams understand risk, opportunity, and competitive positioning faster.
Contact FYLED